Endo, Teikoku Monopoly Claims Likely Out In Lidoderm MDL
A California federal judge said Wednesday he would likely throw out allegations in multidistrict litigation that Endo Pharmaceuticals Inc. and Teikoku Seiyaku Co., Ltd. shared a monopoly in the market for the Lidoderm...To view the full article, register now.
Already a subscriber? Click here to view full article